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Comportements de la (Na+, K+)-ATPase nerveuse et rénalevis.à-yis de la dopamine et~~ 
de l'amphétamine ---~~ 
L'action in vitro de la dopamine (DA) et de l'amphétamine (AMPH) a été étudiée sur la (Na +, K+)-ATPase du bulbe 
olfactif et du rein du rat. La réponse de cette enzyme aux deux drogues dépend enormément de l'organe d'origine 
de la préparation enzymatique surtout pour des doses comprises entre 10-5 et 1O-4M. Sur cette gamme de 
concentration, au niveau rénal, ces deux agents ont exercé une faible inhibition non significative; au niveau 
bulbaire, ils ont induit, en revanche, une stimulation significative dont le maximum est de 102% (DA) et de 25% 
(AMPH). La K+ _pNPPase a présenté le même comportement que la (Na +, K+)-ATPase. Celui -ci dépend, également, 
de l'organe d'origine de la préparation enzymatique. Cet effet stimulateur disparaît lorsque la préparation 
enzymatique d'origine nerveuse est traitée par le triton X 100 (0,03%). Les résultats de ce travail montrent que la 
DA et l'AMPH (10-5 à 1O-4M) n'ont pas d'effet direct sur la (Na+, K+)-ATPase nerveuse. l'effet stimulateur 
"apparent" pourrait être dû à une interaction entre ces drogues et l'environnement membranaire de l'enzyme au 
nivau de la cellule nerveuse. 
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Behaviour of neural and renal (Na+, K+)- ATPase to dopamine and amphetamine -----------, 
The action of dopamine (DA) and amphetamine (AMPH) on the (Na+, K+)-ATPase from the rat olfactory bulb and 
kidney was studied in vit/o. The effects ofthe drugs depended greatly on the organ from which the enzyme was 
extracted, particularly in the concentration range 10-5 to 10-4 M. In this range the two agents produced a weak 
(non-significant) inhibition of activity in the kidney enzyme, while producing a very significant stimulation 
(maximum 102% for DA and 25% for AMPH) in the olfactory bulb enzyme. The same effects were also observed on 
the K+ -pNPPase, which showed a behaviour dependent on the organ from which it was extracted. The stimulatory 
effect disappeared once the neural enzyme preparation was treated with triton X100 (0.03%). These results are 
consistent with the the ory that the stimulatory effect is attributable to an interaction between the drugs and the 
membrane environment of the enzyme in nerve cells. 
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INTRODUCTION 
The (Na+, K+)-ATPase (sodium pump) plays a 
major role in cellular function. It ensures the 
transport of Na+ and K+ ions against their 
electrochemical potential gradients across animal' 
cell membranes. In the kidney, it plays a role in the 
membrane transport of glucose (Kinne et al., 
1975), amino acids (Evers et al., 1976), citrate and 
lactate (Kinne and Schwartz, 1978). In the brain , 
it can intèrvène in the release of 
neurotransmitters (Mc Millen, 1983). 
The involvement ofthe neural sodium pump in the 
release of catecholamine and, notably, of dopamine 
(DA) under the influence of amphetamine (AMPH) 
(Mc Millen, 1983) suggests that this drug may act 
on the activity of (Na+, K+)-ATPase. In fact, sorne 
studies have already described the action in vitro 
of different drugs ( phenobarbital, ouabain ... ) on 
this activity (Deliconstantinos 1983; Lichtsteinet 
al., 1985). The response is often biphasic : 
stimulation at weak doses (10-7 to 1O-5M) and 
inhibition at strong doses (10-3 to 1O-2M) ofthese 
drugs. While the inhibitory effect at strong doses is 
widely accepted, the stimulation at weak doses is 
not weIl characterised. -With the aim of 
determining how weak doses of pharmacological 
agents might induce stimulation, the present 
paper studies the actions in vitro of AMPH and DA 
on membrane preparations obtained from total 
homogenization of the olfactory bulb of the rat. 
Given the fact that sorne studies (Jensen & 
Ottolenghi 1976) have shown that the activity of 
(Na+, K+)-ATPaseis very sensitive to 
perturbations of the lipid bilayer, we have also 
studied the effects of treatment with a detergent. 
In these conditions, we have shown (unpublished) 
that triton X 100 (TX 100) (the detergent used in 
the present work) at certain doses does not 
denature the enzyme protein but does perturb the 
lipid environment of the enzyme. 
The activity of (Na+, K+)-ATPase follows a cycle 
with phosphorylation offtrre ,enzyme being foUowed 
by dephosphorylation.The cilephosphorylation 
step is coupled to a K+ -depeilIdent phosphatase 
activity (Robinson,1973). This is usually evaluated 
by studying the K+ -p-nitrophenylphosphatase 
(K+ -pNPPase) activity ( Swann, 1984). The actions 
of AMPH and DA will therefore also be studied on 
this enzyme. 
Finally, the behaviour of (Na+, K+)-ATPase from 
the kidney will also be subjected to the same 
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procedures .to provide a compaI"ison with the 
behaviour of the neuronal preparation. 
MATERIAL & METHODS 
1. Enzymatic preparation 
The animaIs used in this experiment were adult 
female albinos wistar rats (Ratus norvegicus) 
weighing about 300g. After decapitation, th~ 
forebrain, including both olfactory bulbs or kidney 
were quickly removed and kept in ice cold 0,25 M 
sucrose solution. 
For the olfcatory bulb, homogenization was done 
directly in a Potter-Elvenhjen grinder type AA. For 
the kidney, disagregation was initiated in an 
Ultra-Turrax homogenizer and finished in a 
Potter-Elvenhjen. For both tissues, the 
. homogenization was done in a solution of 0,25 M 
sucrose. The volume was chosen to give a 
convenient concentration of proteins for the 
enzymatic reactions to occur. The homogenates 
were placed in closed tubes, frozen at-18°C and 
kept for 24 hours in the freezer before biochemical 
evalution. Protein content was measured using 
the method of Lowry et al. (1951). Bovine serum 
albumin was used as a standard. 
2. Enzymatic activity measurement 
• (Na+, K+)-ATPase 
(Na+, K+)-ATPase activity was estimated by 
measuring the quantity of inorganic phosphate 
(Pi) produced during an incubation (with or 
without drugs) for 15 minutes in an agitation bath 
thermostated at 37°C in the presence of excess 
ATP substrate. The method for measuring Pi was 
that of Baginski et al. (1967). The medium used for 
the estimation of totalATPase activitycontained: 
Tris-HCI buffer, pH 7,4: 100 mM; MgCI2: 3 mM; 
NaCI: 100 mM; KCl: 30 mM. Mg++-ATPase 
activity was measured in a medium containing: 
Tris-HCI buffer, pH 7,4: 100 mM; MgCI2: 3 mM; 
NaCl: 130 mM; ouabain: 1 mM. Ouabain-sensitive 
ATPase activity( (Na+, K+)-ATPase) was obtained 
bysubtracting Mg++-ATPase from total ATPase 
activity. 
• K+ -pNPPase 
K+ -pNPPase activity was estimated by measuring 
the quantityof p-nitrophenol (pNP) produced 
during an incubation (with or without drugs)for 15 
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minutes in an agitation bath thermostated at 37°C 
in the presence of p-nitrophenylphosphate 
(pNPP). The pNP produced following the 
transformation of pNPP reacted immediately with 
NaOH (0,2M) to produce a yellow colour. The 
medium used for the estimation of total pNPPase 
activity contained: Tris-HCI buffer, pH 7,4: 100 
mM; MgCI2: 5 mM; KCI: 30 mM. Mg++ -pNPPase 
activity was measured in a medium containing: 
Tris-HCI buffer, pH 7,4: 100 mM; MgCI2: 5 mM; 
KCI : 30 mM; ouabain: 1 mM. Ouabain-sensitive 
pNPPase activity (K+ -pNPPase) was obtained by 
subtracting Mg++ -pNPPase from total pNPPase 
activity. 
3. Triton X 100 treatment of enzymatic 
preparations 
Detergent treatment of enzymatic preparations 
was carried out as follows: Triton X 100 ( TX100) 
was dissolved in water at 0,06 per cent 
concentration. 0,5 ml ofthis solution was added to 
0,5 ml of enzyme suspension. Activity of 0,1 ml of 
the enzyme-detergent mixture ( 0,03% of TX100) 
was determined immediately following 
preincubation at O°C for 15 min. 
4. Data analyses 
AlI results are means ESM of five separate 
homogenate preparations and they are expressed 
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as the pourcentage of activity measured in the 
absence of drug (control, 100%). The statistical 
significance of differences between control and 
treatments was determined using Student's t-test. 
N.B. : non significant ; *: 0,001 < p < 0,05 ; **: p < 0,001 
RESULTS 
1. Protein levels and enzyme activities in the 
olfcatory bulb and kidney 
In table 1 the results are presented as a 
comparison between the two tissues and show: 
- The level of proteins in the olfactory bulb is 
around 70% of that in the kidney. 
- The basal activities (Mg++-ATPase and Mg++-
pNPPase) are 2 to 3 times higher in the kidney. 
iii) The stimulated activities (Na+, K+)-ATPase 
and K+ -pNPPase show nearly the same level in 
the two tissues. iv) T X 100 at 0.03% produces in 
general an activation of the different enzymes, 
ranging from 30 to 80%. 
2. Action of increasing doses of ampheta-
mine and dopamine on the activities of 
Mg++-ATPase and Mg++-pNPPase in vitro 
The basal levels of activity did not change 
significantly under theiIlfluence of AMPH and DA. 
Tabl~s 2 & 3 summarize the behaviour of Mg++-
ATPase and Mg++ -pNPPase in response to two 
Table 1. Protein content and specifie activities of ATPases and pNPPases in olfctory bulb and kidney 
Tissue Proteina MJtt-ATPaseb (Na+K+)ATPasb Mgtt -pNPPaseC K+ pNPPase c 
CP TX100 Cpd TX100 Cpd TX100 Cpd TX100 
Olfactory bulb 124±4 9,23 ±0,27 8,63 ±0,31 5,51 ± 0,30 9,36 ±0,80 1,22 ±0,08 1,65 ±0,03 1,08 ± 0,20 1,38±O,10 
(26) (7) (4) (7) (4) (6) (4) (6) (4) 
Kidney 167±5 18,40±0,60 16,20 ± 0,50 4,40 ± 1,10 8,00 ± 1,00 3,27±0,10 4,17±0,10 0,84 ± 0,20 1,13 ± 0,20 
(15) (5) (4) (5) (4) (4) (4) (4) (4) 
Each value represents the mean ± S.E. of the number of separate homogenate preparations given in parentheses. 
a : mg/g de tissu; b : mmoles Pi/mg protlh ; c : mmoles pNP/mg prot/h ; d : Control preparation 
Table 2. Effects of DA and AMPH (3xH}"5 M and lo-2M) on Mg++.ATPase activity in olfactory bulb and 
kidney 
Olfactory bulb 
Kidney 
Without drugs 
100% 
100% 
DA 30 mM 
95 ±4 N.S. 
102 ± 4 N.S. 
AMPH 30 mM 
100±6N.S. 
103±4 N.S. 
DA 10000 mM 
71 ± 3* 
79 ± 3 * 
AMPH 10000mM 
72,5 ± 3* 
69,5±3 * 
Table 3. Effects of DA and AMPH (3xlo-5 and lo-2M) on Mg++ .pNPPase activity in olfactory bulb and 
kidney 
Olfactory bulb 
Kidney 
Withoul drugs DA 30 mM AMPH 30 mM DA 10000 mM AMPH10000 mM 
100% 
100% 
101 ±5 N.S. 
102,5 ± 6 N.S. 
105,7 ± 5 N.S. 
104±5N.S. 
74±3* 
90±4* 
86 ±3* 
90,5±3* 
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dose levels that induced the largest effects on the 
(Na+, K+)-ATPase and K+ pNPPase activity 
levels. At 3 x 10-5 M neither of the two drugs had 
a significant effect. By contrast, at 10-2 M both 
compounds had a significant inhibitory effect (10 
to 30%). 
3. Action of increasing doses of amphetamine 
and dopamine on the activities of (Na+, K+)-
ATPase and K+ -pNPPase in vitro 
Figures 1 and 2 show that (Na+, K+)-ATPase and 
K+-pNPPase behave in a similar way under the 
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influence of AMPH and DA and that the hebaviour 
ofboth depends on the tissue from which they were 
extracted. IIv the case of the kidney (right hand 
panels), both agents produce a dose-dependent 
inhibition, which is more striking in the case of 
AMPH. In the case ofthe olfcatory bulb (left hand 
panels), both produce a biphasic effects on both 
enzymes: i.e. a very significant stimulation which 
reaches maximal effects at 80-102% for DA (at 
1O-4M) and 20-25% for AMPH (at 3 x 1O-5M). Only 
at 1O-2M do these agents produce a significant 
inhibition (between 50 and 80%) ofboth enzymes. 
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Figure 1. Effects ofvarious concentrations of DA and AMPH on (N a+, K + )-ATPase activity in olfactory bulb 
andkidney 
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Figure 2. Effects ofvarious concentrations of DA and AMPH on K +·pNPPase activity in olfactory bulb and 
kidney 
It is clear that TX 100 (0.03%) has no influence on 
the effects of either drug on the renal enzymes. By 
contrast, it significantly reduced mid even 
abolished the stimulatory effect of weak doses on 
enzymes from the olfactory bulb. For the two 
drugs, the remaining effect (when it existed) did 
not exceed 10% and was not significant. 
DISCUSSION 
Regulation of the (Né K+)-ATPase by different 
factors has been demonstrated by a variety of 
hormones (Johnson et al., 1986; Gick & Ismail-
Beigi, 1990). neurotransmitters (Hernandez-R, 
1992; Vizi & Oberfrank, 1992) and other 
endogenous factors (Hamlyn et al., 1991). DA has 
been shown to inhibit the (N a+, K+)-ATPase in the 
kidney (Bertorello & Aperia, 1990), brain 
(Bertorello et al., 1990) and rat tail arteries 
(Rashed & Songy-Mize, 1995). 
In the this study we investigated the regulation 
the neural (Na+, K+)-ATPase activiy by DA and 
AMPH, and identified some of mechanisms 
involved in the stimula tory effect obtained 
between 10-5 and 1O-4M ofthese drugs. 
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The results reported here show that the response 
of the (Na+, K+)-ATPase to DA and AMPH 
depends greatly on the organ from which the 
enzyme preparation is made. Our results show 
that between 10-5 and 10-4 M the neural (Na +, 
K+)-ATPase is much more sensitive to DA than to 
AMPH. The stimulatory effect of the former can 
reach an increase102%, while the latter pro duces 
only 25%. 
By contrast, in the kidney, the stimulatory effect is 
absent. this difference between neural and renal 
enzymes is consistent with the the ory that 
catecholamines uptake (DA) in neurons involves 
transportation of amines from the synaptic cleft to 
the neuronal cytoplasm, wich is facilitated by 
(Na+, K+)-ATPase. This difference betweenneural 
and renal enzymes could be explained by the 
existence oftwo isomers of(Na+, K+)-ATPase: a(+) 
is predominant in the central nervous system 
(CNS) while a exists in kidney (Sweadner, 1979). 
The structural and physico-chemical properties of 
these two isomers are, doubtless, responsible for 
different responses to pharmacological agents. 
These isoforms can be characterized by isoform -
specific pharmacologic properties (Shyjan et al., 
1990; Jewell & Lingrel, 1991), suggesting that 
there may be isoform-specific funcions in cell of the 
CNS and kidney. 
Our results show that this stimulatory effect 
disappears when the CNS enzyme preparation is 
treated with T X 100 at 0,03%. By contrast, this 
treatment has no effect on the kidney enzyme 
preparation. These results are consistent with 
those of Matsuda & Iwata (1986) who show that 
the form ex (+) is more sensitive to the action of 
phospholipase than the form ex. Our results also 
show that a similar, organ-dependent, difference 
exists for the K+ -pNPPase. 
These results, as a whole, show that , at weak 
concentrations (10-5 to 1O-4M), DA and AMPH do 
not act directly on the neural (Na+, K+)-ATPase. 
The apparent stimulatory effect could rather be 
due to a non-specific interaction between these 
pharmacological agents and the lipid environment 
of the (N a+, K+)-ATPase (Peters, 1977). 
In physiological conditions, this environment 
exerts an inhibitory effect on the enzyme molecule 
(Deliconstantinos, 1983; Lichststein et al., 1985). 
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The augmentation of activity by weak 
concentrations of drug is therefore better 
represented as a removal of these environmental 
constraints : a form of "disinhibition" similar to 
that postulated already for the low dose 
stimulatory effects of cardiac glycosides 
(Lichtstein et al., 1985). 
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